联邦制药(03933)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03933 联邦制药

交易中 12-19 15:36:02

12.490

+0.370

+3.05%

最高12.620	最低12.160	成交量818.99万
今开12.210	昨收12.120	日振幅3.80%
总市值246.43亿	流通市值246.43亿	总股本19.73亿
成交额1.02亿	换手率0.42%	流通股本19.73亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03933","market":"HK","secType":"STK","nameCN":"联邦制药","latestPrice":12.49,"timestamp":1766129718535,"preClose":12.12,"halted":0,"volume":8189880,"delay":0,"floatShares":1973000000,"shares":1973000000,"eps":1.6192766448158868,"marketStatus":"交易中","change":0.37,"latestTime":"12-19 15:36:02","open":12.21,"high":12.62,"low":12.16,"amount":101648066,"amplitude":0.037954,"askPrice":12.5,"askSize":44000,"bidPrice":12.48,"bidSize":20000,"shortable":3,"etf":0,"ttmEps":1.8646240378497834,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1766131800000},"marketStatusCode":2,"adr":0,"listingDate":1181836800000,"exchange":"SEHK","adjPreClose":12.12,"dividendRate":0.038594,"openAndCloseTimeList":[[1766107800000,1766116800000],[1766120400000,1766131200000]],"volumeRatio":1.234194,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03933","defaultTab":"news","newsList":[{"id":"2592513686","title":"【券商聚焦】交银国际：临近年末 续看好新BD交易集中落地机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2592513686","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592513686?lang=zh_cn&edition=full","pubTime":"2025-12-19 09:20","pubTimestamp":1766107245,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报，本周多项超10亿美元的BD交易相继落地，合作伙伴既有MNC也有中小型生物科技公司。临近年末，该机构继续看好新BD交易集中落地机会。展望2026 年，该机构认为板块稳中向好态势延续，但影响市场表现的核心因素或呈分化态势，后续选股逻辑或将重回基本面和估值，即关注存在基本面预期差、当前仍被低估的个股。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/YzM1MzBiNWM5MmUxNDYxMGFiODk0MWI5MWJmNTU3YjMxMTA4MTkwNzI1ODY3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YzM1MzBiNWM5MmUxNDYxMGFiODk0MWI5MWJmNTU3YjMxMTA4MTkwNzI1ODY3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971853","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","BK1585","LU2328871848.SGD","LU2399975544.HKD","BK1593","LU0540923850.HKD","LU2778985437.USD","LU0417516738.SGD","BK1588","LU0417516571.SGD","LU0588546209.SGD","LU1251922891.USD","01789","02196","LU0634319403.HKD","LU0561508036.HKD","02367","HK0000165453.HKD","BK1617","02268","LU0348766576.USD","LU1794554557.SGD","LU0348735423.USD","IE00B543WZ88.USD","LU0348825331.USD","BK1583","LU0417516902.SGD","06160","LU1115378108.SGD","LU2488822045.USD","LU2476274308.USD","LU0307460666.USD","LU1720050803.USD","IE00B5MMRT66.SGD","BK1147","LU0348784397.USD","03329","03933","LU1303224171.USD","SG9999014674.SGD","01099","LU1770034418.SGD","01530","BK1191","02228","09926","BK1197","LU2476274720.SGD","LU0348783233.USD","09688"],"gpt_icon":0},{"id":"2592053185","title":"每日卖空追踪 | 联邦制药 12月18日卖空量成交18万股，卖空比例为4.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592053185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592053185?lang=zh_cn&edition=full","pubTime":"2025-12-18 16:30","pubTimestamp":1766046633,"startTime":"0","endTime":"0","summary":"联邦制药北京时间12月18日，涨0.5%，卖空量成交18万股，较上一交易日减少80.81%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163531a45aa444&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163531a45aa444&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2592973957","title":"诺和诺德：Wegovy®狂飙与9000人裁员背后的GLP-1赛道变局","url":"https://stock-news.laohu8.com/highlight/detail?id=2592973957","media":"摩熵医药","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592973957?lang=zh_cn&edition=full","pubTime":"2025-12-18 11:07","pubTimestamp":1766027230,"startTime":"0","endTime":"0","summary":"2025年第三季度，诺和诺德的核心产品Wegovy销售额同比狂飙54%，但公司随之而来的决定却让很多人吃了一惊：全球裁员9000人。截至12月10日收盘，诺和诺德股价报收于49.05美元，较前一日上涨5.8%，市值重回2170亿美元以上。诺和诺德在美国的“高增长”依赖的是Wegovy的爆发式放量，而非整体产品线扩张。诺和诺德虽凭Wegovy实现高增长，却因技术代差、市场饱和与研发滞后被迫战略收。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218110738a4597356&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218110738a4597356&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2097828714.EUR","HK0000165453.HKD","LU2097828631.EUR","LU2097828805.USD","LU2097828557.USD","LU0455707207.USD","03933","LU2097828474.EUR","01276","LU2328871848.SGD","02196","BK1589","01801","LU2488822045.USD","BK1161","LU2242644610.SGD","LU0502904849.HKD","LU1969619763.USD","BK1583"],"gpt_icon":0},{"id":"2591657861","title":"医药生物行业周报：2025国谈结果公布 关注相关公司投资机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2591657861","media":"开源证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591657861?lang=zh_cn&edition=full","pubTime":"2025-12-14 00:00","pubTimestamp":1765641600,"startTime":"0","endTime":"0","summary":"2025 国谈结果重磅公布，关注相关公司投资机会12 月7 日，国家医保局重磅发布2025 年医保谈判结果，此外还首次同步启动了商保目录的制定工作。2025 医保目录新增114 种药品，总体成功率达88%，谈判成功率创近7 年新高，最高降幅94%，新版目录自2026 年1 月1 日起正式执行。12 月第2 周医药生物下跌1.04%，医疗研发外包板块涨幅最大从月度数据来看，2025 年初至今沪深整体呈现上行趋势。本周医药生物下跌1.04%，跑输沪深300 指数0.96pct，在31 个子行业中排名第17 位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214143634a4495150&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214143634a4495150&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","03933","BK1574","01801","01167","06160","06978"],"gpt_icon":0},{"id":"2590725265","title":"巨头卷向“三重靶点”减重药，国内价格战即将打响","url":"https://stock-news.laohu8.com/highlight/detail?id=2590725265","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590725265?lang=zh_cn&edition=full","pubTime":"2025-12-12 17:36","pubTimestamp":1765532204,"startTime":"0","endTime":"0","summary":"巨头押注“三重靶点”减重药当地时间12月11日，礼来发布数据称，该公司在研的新一代GLP-1类减重药retatrutide在一项后期临床试验中帮助患者减重近29%。目前礼来的替尔泊肽不同剂量可帮助患者减重15%至21%。届时，礼来与竞争对手诺和诺德的竞争将延伸至口服减重药领域。与糖尿病药物相比，用于减重适应症的治疗药物的定价通常较高。而随着大量仿制药的上市，2026年，一场GLP-1药物的价格战也即将打响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212173720a69ba0b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212173720a69ba0b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1066053197.SGD","IE00BKVL7J92.USD","BK4581","03933","SGXZ57979304.SGD","LU1093756325.SGD","IE00BZ1G4Q59.USD","SG9999001176.USD","SG9999001176.SGD","BK4550","LU0321505868.SGD","LU1057294990.SGD","SG9999011175.SGD","LU0456855351.SGD","BK4585","LU1894683264.USD","LU1894683348.USD","IE00BLSP4452.SGD","BK4534","LU0306807586.USD","01801","BK4599","LU0122379950.USD","SG9999013999.USD","LU0289739699.SGD","SG9999003800.SGD","IE00BBT3K403.USD","LU0225771236.USD","BK4532","LU0170899867.USD","LU0058720904.USD","LU0154236417.USD","NVO","PFE","LU1066051498.USD","SG9999002224.SGD","IE00B19Z3B42.SGD","BK4588","BK4007","LU0234572021.USD","SG9999002232.USD","BK4568","BK4592","BK4160","IE000M9KFDE8.USD","IE0002270589.USD","LU1883839398.USD","LU0321505439.SGD","IE00B19Z3581.USD","LU0985481810.HKD","GIPR","LU1093756168.USD"],"gpt_icon":1},{"id":"2590391509","title":"每日卖空追踪 | 联邦制药 12月12日卖空量成交54.4万股，卖空比例为3.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590391509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590391509?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:30","pubTimestamp":1765528233,"startTime":"0","endTime":"0","summary":"联邦制药北京时间12月12日，跌1.62%，卖空量成交54.4万股，较上一交易日减少26.68%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121216541295398d0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121216541295398d0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2590275559","title":"每日卖空追踪 | 联邦制药 12月10日卖空量成交31.4万股，卖空比例为3.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590275559","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590275559?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:30","pubTimestamp":1765355435,"startTime":"0","endTime":"0","summary":"联邦制药北京时间12月10日，跌1.89%，卖空量成交31.4万股，较上一交易日减少67.76%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210163558979a47a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210163558979a47a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2590559279","title":"联邦制药12月10日主力净流出471.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2590559279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590559279?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:15","pubTimestamp":1765354509,"startTime":"0","endTime":"0","summary":"12月10日, 联邦制药股价跌1.89%，报收12.46元，成交金额1.2亿元，换手率0.47%，振幅2.68%，量比1.62。联邦制药今日主力资金净流出471.8万元，上一交易日主力净流入112.9万元。该股近5个交易日下跌2.43%，主力资金累计净流出1158.1万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入3.8万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210161521a43f9243&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210161521a43f9243&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2590831422","title":"联邦制药(03933)：左氧氟沙星滴眼液通过中国国家药品监督管理局上市审批","url":"https://stock-news.laohu8.com/highlight/detail?id=2590831422","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590831422?lang=zh_cn&edition=full","pubTime":"2025-12-09 17:54","pubTimestamp":1765274063,"startTime":"0","endTime":"0","summary":"智通财经APP讯，联邦制药 发布公告，本公司全资附属公司珠海联邦制药股份有限公司中山分公司申报的左氧氟沙星滴眼液通过中国国家药品监督管理局上市审批，药品批准文号：国药准字H20256135。现时，左氧氟沙星滴眼液为国家医保目录甲类药品。本次获批将进一步拓展联邦制药眼科产品布局，强化本公司于眼科抗感染治疗领域的优势地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379399.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"联邦制药(03933)：左氧氟沙星滴眼液通过中国国家药品监督管理局上市审批","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2589561846","title":"每日卖空追踪 | 联邦制药 12月05日卖空量成交16.8万股，卖空比例为2.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589561846","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589561846?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:30","pubTimestamp":1764923433,"startTime":"0","endTime":"0","summary":"联邦制药北京时间12月05日，涨0.62%，卖空量成交16.8万股，较上一交易日减少80.73%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120516352197918124&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120516352197918124&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2589465958","title":"联邦制药12月05日主力净流入99.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2589465958","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589465958?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:15","pubTimestamp":1764922555,"startTime":"0","endTime":"0","summary":"12月05日, 联邦制药股价涨0.62%，报收12.92元，成交金额8071.3万元，换手率0.32%，振幅2.18%，量比1.27。联邦制药今日主力资金净流入99.8万元，上一交易日主力净流出899.0万元。该股近5个交易日上涨2.11%，主力资金累计净流入579.9万元；近20日主力资金累计净流出3494.9万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120516212597917a35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120516212597917a35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2589402852","title":"【券商聚焦】交银国际：医药行业短期催化剂充足 长期继续看好创新主线","url":"https://stock-news.laohu8.com/highlight/detail?id=2589402852","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589402852?lang=zh_cn&edition=full","pubTime":"2025-12-05 10:38","pubTimestamp":1764902337,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，2025年10月以来，内资通过港股通持有医药股的比例小幅下降，外资持仓从年中起亦呈回落态势，但内外资加大创新药布局的大方向不变。而外资则更积极，聚焦创新主线中的龙头及产业链上游，包括恒瑞医药、君实生物和荣昌生物等创新药，及康龙化成、药明康德和泰格医药等CXO标的。12月，行业仍有充足催化剂，包括各项学术大会、医保谈判结果公布、美联储潜在降息等，板块投资情绪有望稳中有升。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970976","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","HK0000165453.HKD","LU0417516738.SGD","02268","LU1251922891.USD","LU0348825331.USD","BK1583","02228","LU1969619763.USD","LU2476274308.USD","02367","BK1161","IE00BPRC5H50.USD","LU0417516902.SGD","LU0588546209.SGD","LU1794554557.SGD","LU2399975544.HKD","09926","03933","LU2778985437.USD","IE00B5MMRT66.SGD","LU0348827113.USD","LU0417516571.SGD","BK1500","LU0640798160.USD","02196","LU0634319403.HKD","BK1141","BK1588","BK1585","LU2328871848.SGD","LU0540923850.HKD","IE00B543WZ88.USD","LU1770034418.SGD","01530","BK1593","BK1197","01099","01789","06160","BK1147","BK1617","LU0348766576.USD","LU1303224171.USD","LU2476274720.SGD","LU0561508036.HKD","SG9999004311.SGD","03329","09688","SG9999014674.SGD"],"gpt_icon":1},{"id":"1121709312","title":"联邦制药国际控股（3933）11月股份月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1121709312","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121709312?lang=zh_cn&edition=full","pubTime":"2025-12-03 17:20","pubTimestamp":1764753628,"startTime":"0","endTime":"0","summary":"联邦制药国际控股有限公司（03933）于2025年12月3日披露2025年11月股份变动月报，报告期为2025年11月1日至11月30日。\n公司普通股法定及注册股本与上月一致，注册股本维持在3,800,000,000股，面值每股0.01港元，总注册股本38,000,000港元。截至11月末，已发行股份总数为1,973,026,508股，较上月底无新增发行或回购注销记录，库藏股数目仍为0股。\n本月亦无任何股份期权、可换股票据及其他类似工具的发行或变动。公司确认所有相关交易均已遵守香港联交所《上市规则》和相关法律法规。\n本次月报由公司秘书梁永康签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933"],"gpt_icon":0},{"id":"2588010862","title":"每日卖空追踪 | 联邦制药 12月03日卖空量成交59.6万股，卖空比例为12.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588010862","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588010862?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:30","pubTimestamp":1764750631,"startTime":"0","endTime":"0","summary":"联邦制药北京时间12月03日，股价较前一交易日持平，卖空量成交59.6万股，较上一交易日减少26.24%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163530978d7bf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163530978d7bf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2588082848","title":"联邦制药TUL01101片启动Ⅰ期临床 适应症为中重度特应性皮炎","url":"https://stock-news.laohu8.com/highlight/detail?id=2588082848","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588082848?lang=zh_cn&edition=full","pubTime":"2025-12-02 12:03","pubTimestamp":1764648180,"startTime":"0","endTime":"0","summary":"药物临床试验登记与信息公示平台数据显示，珠海联邦制药股份有限公司的评价不同规格TUL01101片在中国健康受试者中的相对生物利用度研究的Ⅰ期临床试验已启动。本次试验主要目的为评价TUL01101片不同处方工艺的新旧规格在健康成人受试者空腹条件下单次口服给药的药代动力学特征和相对生物利用度；次要目的为评价健康成人受试者单次口服不同处方工艺的新旧规格TUL01101片的安全性。TUL01101片为化学药物，适应症为中重度特应性皮炎。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202130122978b1235&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202130122978b1235&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2588748097","title":"每日卖空追踪 | 联邦制药 12月01日卖空量成交42.6万股，卖空比例为7.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588748097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588748097?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:30","pubTimestamp":1764577834,"startTime":"0","endTime":"0","summary":"联邦制药北京时间12月01日，涨0.23%，卖空量成交42.6万股，较上一交易日减少55.99%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116352895244986&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116352895244986&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2588774874","title":"联邦制药12月01日获主力加仓885.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588774874","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588774874?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:15","pubTimestamp":1764576958,"startTime":"0","endTime":"0","summary":"12月01日, 联邦制药股价涨0.23%，报收12.80元，成交金额7099.2万元，换手率0.28%，振幅2.27%，量比0.51。联邦制药今日主力资金净流入885.7万元，连续4日净流入，上一交易日主力净流入3.7万元。近一年数据显示，该股主力连续4日净流入后，次日上涨概率为61.54%，平均涨幅为2.79%。该股近5个交易日上涨5.92%，主力资金累计净流入2415.0万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流出2096.1万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201162125a71c6921&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201162125a71c6921&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2586237699","title":"联邦制药(03933)：注射用头孢哌酮钠舒巴坦钠通过一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2586237699","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586237699?lang=zh_cn&edition=full","pubTime":"2025-11-26 17:08","pubTimestamp":1764148110,"startTime":"0","endTime":"0","summary":"智通财经APP讯，联邦制药 发布公告，公司全资附属公司珠海联邦制药股份有限公司中山分公司申报的注射用头孢哌酮钠舒巴坦钠经中国国家药品监督管理局审批，通过仿制药质量和疗效一致性评价。注射用头孢哌酮钠舒巴坦钠是第三代头孢菌素类抗生素，具有广谱抗菌活性，可单独或联合用药。现时，注射用头孢哌酮钠舒巴坦钠为国家医保目录乙类药品。此外，本次获批将进一步有助于公司巩固于抗感染领域的优势地位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373897.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"1178063525","title":"联邦制药 - 注射用头孢哌酮钠和舒巴坦钠通过Nmpa一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=1178063525","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178063525?lang=zh_cn&edition=full","pubTime":"2025-11-26 17:02","pubTimestamp":1764147739,"startTime":"0","endTime":"0","summary":"联邦制药 - 注射用头孢哌酮钠和舒巴坦钠通过Nmpa一致性评价","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2586262581","title":"联邦制药11月26日主力净流入584.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2586262581","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586262581?lang=zh_cn&edition=full","pubTime":"2025-11-26 16:15","pubTimestamp":1764144934,"startTime":"0","endTime":"0","summary":"11月26日, 联邦制药股价涨1.11%，报收12.75元，成交金额1.3亿元，换手率0.52%，振幅3.65%，量比0.89。联邦制药今日主力资金净流入584.3万元，上一交易日主力净流出52.1万元。该股近5个交易日上涨7.44%，主力资金累计净流入620.1万元；近20日主力资金累计净流出3867.8万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126161817a4bb5567&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126161817a4bb5567&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tul.com.cn","stockEarnings":[{"period":"1week","weight":-0.021},{"period":"1month","weight":0.0359},{"period":"3month","weight":-0.225},{"period":"6month","weight":-0.2117},{"period":"1year","weight":0.1019},{"period":"ytd","weight":0.0218}],"compareEarnings":[{"period":"1week","weight":-0.0013},{"period":"1month","weight":-0.0167},{"period":"3month","weight":-0.0394},{"period":"6month","weight":0.0836},{"period":"1year","weight":0.2836},{"period":"ytd","weight":0.2711}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"联邦制药国际控股有限公司是一家投资控股公司，主要从事销售中间体产品、原料药及制剂产品业务。该公司通过三个业务部门运营业务。中间体部从事销售中间体产品业务。原料药部从事销售原料药业务。制剂产品部从事销售抗生素制剂产品、非抗生素制剂产品及空心胶囊业务。该公司通过其子公司还从事制造及销售有机化肥业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.036412},{"month":2,"riseRate":0.722222,"avgChangeRate":0.07509},{"month":3,"riseRate":0.666667,"avgChangeRate":0.040428},{"month":4,"riseRate":0.611111,"avgChangeRate":0.081119},{"month":5,"riseRate":0.666667,"avgChangeRate":0.040685},{"month":6,"riseRate":0.277778,"avgChangeRate":-0.012388},{"month":7,"riseRate":0.526316,"avgChangeRate":0.011895},{"month":8,"riseRate":0.473684,"avgChangeRate":0.025474},{"month":9,"riseRate":0.421053,"avgChangeRate":-0.006971},{"month":10,"riseRate":0.631579,"avgChangeRate":-0.000903},{"month":11,"riseRate":0.473684,"avgChangeRate":-0.023163},{"month":12,"riseRate":0.421053,"avgChangeRate":0.013338}],"exchange":"SEHK","name":"联邦制药","nameEN":"UNITED LAB"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"联邦制药(03933)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供联邦制药(03933)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"联邦制药,03933,联邦制药股票,联邦制药股票老虎,联邦制药股票老虎国际,联邦制药行情,联邦制药股票行情,联邦制药股价,联邦制药股市,联邦制药股票价格,联邦制药股票交易,联邦制药股票购买,联邦制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"联邦制药(03933)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供联邦制药(03933)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}